Prevalence of NAFLD in T1DM Patients
Recruiting
N/A
Interventional Study
NAFLD
Type 1 Diabetes
Fatty Liver, Nonalcoholic
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 138 (estimated)
- Sponsor
- Ziekenhuis Oost-Limburg · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To determine the prevalence of NAFLD in T1DM patients.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* T1DM
* ≥ 18 years of age
* Written informed consent obtained
Exclusion Criteria:
* Excessive alcohol use
* Exclusion of other causes of liver disease and secondary causes of liver steatosis
Contacts